The abstract is read at the publisher; the summary is JClub's.
In MCAO mice, inhibiting astrocytic CCL5 with antibodies or Mir324 reduces infarct area and preserves neurological function, linked to enhanced ERK/CREB signaling.
- Why it matters: After ischemic stroke, Ccl5 rises while Mir324 falls in the peri-infarct cortex, but how this axis affects injury and neuronal pathways was unclear.
- What they did: The study used MCAO mice and astrocyte-neuron co-cultures after OGD, testing CCL5 blockade or Mir324 inhibition and measuring ERK/CREB activity; CCR5 was targeted with Maraviroc.
- The result: CCL5 suppression attenuated astrocyte reactivity and microglial activation, protected dendrites and spine density, and reduced neuronal apoptosis, implying CCR5/ERK/CREB pathway modulation as a therapeutic route.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.